Court Place Advisors Increases Stake in Merck & Co (MRK); Aviance Capital Management Increased Its Bce Com New (BCE) Position

April 24, 2018 - By Richard Conner

BCE Inc. (NYSE:BCE) Logo

Court Place Advisors Llc increased its stake in Merck & Co Inc (MRK) by 51.95% based on its latest 2017Q4 regulatory filing with the SEC. Court Place Advisors Llc bought 14,779 shares as the company’s stock declined 4.63% with the market. The institutional investor held 43,227 shares of the health care company at the end of 2017Q4, valued at $2.43 million, up from 28,448 at the end of the previous reported quarter. Court Place Advisors Llc who had been investing in Merck & Co Inc for a number of months, seems to be bullish on the $162.24B market cap company. The stock increased 2.41% or $1.42 during the last trading session, reaching $60.25. About 19.82 million shares traded or 55.13% up from the average. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since April 24, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Aviance Capital Management Llc increased its stake in Bce Inc Com New (BCE) by 10.41% based on its latest 2017Q4 regulatory filing with the SEC. Aviance Capital Management Llc bought 7,856 shares as the company’s stock declined 10.41% with the market. The institutional investor held 83,314 shares of the public utilities company at the end of 2017Q4, valued at $4.00 million, up from 75,458 at the end of the previous reported quarter. Aviance Capital Management Llc who had been investing in Bce Inc Com New for a number of months, seems to be bullish on the $37.86B market cap company. The stock decreased 0.36% or $0.15 during the last trading session, reaching $41.76. About 1.48 million shares traded or 36.20% up from the average. BCE Inc. (NYSE:BCE) has declined 3.54% since April 24, 2017 and is downtrending. It has underperformed by 15.09% the S&P500.

Among 9 analysts covering BCE Inc. (NYSE:BCE), 5 have Buy rating, 1 Sell and 3 Hold. Therefore 56% are positive. BCE Inc. had 23 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Underperform” rating given on Tuesday, October 27 by Macquarie Research. The company was maintained on Friday, February 9 by Barclays Capital. The firm has “Neutral” rating given on Monday, January 4 by Credit Suisse. The stock has “Hold” rating by Canaccord Genuity on Friday, August 7. Citigroup maintained BCE Inc. (NYSE:BCE) rating on Tuesday, July 19. Citigroup has “Neutral” rating and $63 target. The rating was upgraded by Citigroup to “Buy” on Thursday, April 6. The company was downgraded on Thursday, May 26 by Citigroup. The company was maintained on Tuesday, March 21 by Barclays Capital. The firm has “Sector Perform” rating by National Bank Canada given on Friday, November 6. RBC Capital Markets upgraded the stock to “Best Ideas List” rating in Friday, October 16 report.

Aviance Capital Management Llc, which manages about $2.20B and $1.40 billion US Long portfolio, decreased its stake in Ishares Global Energy Etf (IXC) by 10,672 shares to 55,623 shares, valued at $1.98 million in 2017Q4, according to the filing. It also reduced its holding in Spdr Blackstone / Gso Senior Loan Etf (SRLN) by 135,325 shares in the quarter, leaving it with 393,081 shares, and cut its stake in Ishares Iboxx $ High Yield Corporate Bd (HYG).

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 89 analyst reports since August 13, 2015 according to SRatingsIntel. The rating was downgraded by Bank of America to “Neutral” on Wednesday, January 27. The company was maintained on Tuesday, April 17 by Guggenheim. The stock has “Hold” rating by Jefferies on Thursday, August 27. The firm has “Hold” rating given on Monday, February 26 by Jefferies. UBS maintained Merck & Co., Inc. (NYSE:MRK) rating on Friday, August 19. UBS has “Buy” rating and $70 target. The firm has “Outperform” rating by BMO Capital Markets given on Thursday, October 12. Leerink Swann maintained the shares of MRK in report on Monday, October 30 with “Market Perform” rating. The rating was upgraded by Piper Jaffray to “Overweight” on Thursday, January 12. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) on Tuesday, January 16 with “Hold” rating. As per Tuesday, February 13, the company rating was upgraded by DZ Bank.

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.12, from 1.06 in 2017Q3. It turned negative, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. Washington Tru Co holds 0.15% or 46,828 shares. Schmidt P J Inv Incorporated reported 0.98% stake. Woodstock Corporation reported 125,946 shares. 5,327 are owned by Snow Capital Mngmt Limited Partnership. Franklin Resource owns 1.17% invested in Merck & Co., Inc. (NYSE:MRK) for 43.22M shares. 17.16M are held by Boston Prtnrs. Commerzbank Aktiengesellschaft Fi reported 0.33% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Wade G W And accumulated 0.13% or 19,633 shares. Bridgeway Management owns 253,575 shares or 0.15% of their US portfolio. Sumitomo Mitsui Asset Management Ltd, Japan-based fund reported 265,781 shares. Shine Investment Advisory Service, Colorado-based fund reported 6,681 shares. Moreover, Smith Salley And has 0.95% invested in Merck & Co., Inc. (NYSE:MRK) for 94,186 shares. Union Bancshares has 25,096 shares for 0.44% of their portfolio. Gfs Advisors Ltd Liability Company has invested 1.17% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Pictet Bank & Trust And Ltd reported 0.66% in Merck & Co., Inc. (NYSE:MRK).

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>